NIAGEN BIOSCIENCE, INC. (NAGE) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
44/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseNAGE / S&P -27.66% / 15.20% |
LoseNAGE / S&P 10.99% / 15.00% |
LoseNAGE / S&P -14.29% / 50.40% |
| 2026-Q11/3 |
LoseNAGE / S&P -30.66% / -4.33% |
WinNAGE / S&P 20.84% / 11.30% |
LoseNAGE / S&P 23.53% / 27.70% |
| 2025-Q42/3 |
LoseNAGE / S&P -31.83% / 2.65% |
WinNAGE / S&P 29.95% / 9.00% |
WinNAGE / S&P 100.00% / 13.40% |
| 2025-Q32/3 |
LoseNAGE / S&P -35.25% / 8.12% |
WinNAGE / S&P 36.04% / 4.61% |
WinNAGE / S&P 2300.00% / 13.45% |
| 2025-Q22/3 |
WinNAGE / S&P 108.84% / 10.94% |
WinNAGE / S&P 35.89% / 4.83% |
LoseNAGE / S&P -1150.00% / 10.63% |
| 2025-Q12/3 |
WinNAGE / S&P 29.94% / -4.27% |
WinNAGE / S&P 29.77% / 4.98% |
LoseNAGE / S&P -440.00% / 10.57% |
| 2024-Q42/3 |
WinNAGE / S&P 45.48% / 2.41% |
WinNAGE / S&P 19.18% / 5.25% |
LoseNAGE / S&P -242.86% / 6.15% |
| 2024-Q32/3 |
WinNAGE / S&P 33.70% / 5.89% |
WinNAGE / S&P 9.95% / 5.89% |
LoseNAGE / S&P -111.11% / 6.11% |
| 2024-Q21/3 |
LoseNAGE / S&P -21.55% / 4.28% |
WinNAGE / S&P 5.74% / 5.38% |
LoseNAGE / S&P -77.78% / 5.12% |
| 2024-Q12/3 |
WinNAGE / S&P 143.36% / 10.56% |
WinNAGE / S&P 7.52% / 5.71% |
LoseNAGE / S&P -66.67% / 5.59% |
| 2023-Q41/3 |
LoseNAGE / S&P -2.05% / 11.69% |
WinNAGE / S&P 15.99% / 6.81% |
LoseNAGE / S&P -69.57% / 7.78% |
| 2023-Q31/3 |
LoseNAGE / S&P -7.01% / -3.27% |
WinNAGE / S&P 21.15% / 7.52% |
LoseNAGE / S&P -67.86% / -5.03% |
| 2023-Q21/3 |
LoseNAGE / S&P 2.61% / 8.74% |
WinNAGE / S&P 17.20% / 9.50% |
LoseNAGE / S&P -77.50% / -8.57% |
| 2023-Q10/3 |
LoseNAGE / S&P -8.93% / 7.50% |
LoseNAGE / S&P 10.46% / 10.77% |
LoseNAGE / S&P -61.54% / -15.69% |
| 2022-Q41/3 |
WinNAGE / S&P 36.59% / 7.56% |
LoseNAGE / S&P 6.82% / 11.88% |
LoseNAGE / S&P -42.50% / -17.99% |
| 2022-Q30/3 |
LoseNAGE / S&P -26.35% / -4.88% |
LoseNAGE / S&P 5.65% / 13.47% |
LoseNAGE / S&P -34.88% / -1.41% |
| 2022-Q20/3 |
LoseNAGE / S&P -32.11% / -16.10% |
LoseNAGE / S&P 11.37% / 13.71% |
LoseNAGE / S&P 8.11% / 11.04% |
| 2022-Q11/3 |
LoseNAGE / S&P -34.22% / -4.60% |
WinNAGE / S&P 17.50% / 15.97% |
LoseNAGE / S&P 11.43% / 42.23% |
| 2021-Q40/3 |
LoseNAGE / S&P -40.35% / 11.03% |
LoseNAGE / S&P 13.82% / 15.00% |
LoseNAGE / S&P NAGE unavailable / 96.40% |
| 2021-Q31/3 |
LoseNAGE / S&P -36.41% / 0.58% |
WinNAGE / S&P 14.47% / 10.77% |
LoseNAGE / S&P NAGE unavailable / 69.42% |
| 2021-Q21/3 |
LoseNAGE / S&P 5.57% / 8.55% |
WinNAGE / S&P 13.21% / 6.58% |
LoseNAGE / S&P NAGE unavailable / 51.81% |
| 2021-Q12/3 |
WinNAGE / S&P 94.58% / 6.17% |
WinNAGE / S&P 17.80% / -1.06% |
LoseNAGE / S&P NAGE unavailable / 7.39% |
| 2020-Q42/3 |
WinNAGE / S&P 19.70% / 12.15% |
WinNAGE / S&P 28.01% / -3.72% |
LoseNAGE / S&P NAGE unavailable / -33.42% |
| 2020-Q31/3 |
LoseNAGE / S&P -12.64% / 8.93% |
WinNAGE / S&P 34.62% / -2.04% |
LoseNAGE / S&P NAGE unavailable / -27.10% |
| 2020-Q22/3 |
WinNAGE / S&P 40.80% / 20.54% |
WinNAGE / S&P 42.88% / -0.46% |
LoseNAGE / S&P NAGE unavailable / -27.11% |
| 2020-Q11/3 |
LoseNAGE / S&P -24.36% / -19.60% |
WinNAGE / S&P 44.38% / 3.47% |
LoseNAGE / S&P NAGE unavailable / -14.75% |
| 2019-Q42/3 |
WinNAGE / S&P 9.39% / 9.07% |
WinNAGE / S&P 46.69% / 5.36% |
LoseNAGE / S&P NAGE unavailable / 2.99% |
| 2019-Q31/3 |
LoseNAGE / S&P -15.27% / 1.70% |
WinNAGE / S&P 40.80% / 5.02% |
LoseNAGE / S&P NAGE unavailable / 0.21% |
| 2019-Q22/3 |
WinNAGE / S&P 10.98% / 4.30% |
WinNAGE / S&P 36.99% / 6.64% |
LoseNAGE / S&P NAGE unavailable / 8.65% |
| 2019-Q12/3 |
WinNAGE / S&P 22.16% / 13.65% |
WinNAGE / S&P 43.60% / 8.12% |
LoseNAGE / S&P NAGE unavailable / 14.29% |
| 2018-Q41/3 |
LoseNAGE / S&P -20.05% / -13.52% |
WinNAGE / S&P 76.96% / 9.05% |
LoseNAGE / S&P NAGE unavailable / 18.23% |
| 2018-Q31/3 |
WinNAGE / S&P 15.63% / 7.71% |
LoseNAGE / S&P NAGE unavailable / 10.21% |
LoseNAGE / S&P NAGE unavailable / 19.06% |
| 2018-Q20/3 |
LoseNAGE / S&P -11.67% / 3.43% |
LoseNAGE / S&P NAGE unavailable / 9.03% |
LoseNAGE / S&P NAGE unavailable / 14.46% |
| 2018-Q10/3 |
LoseNAGE / S&P -28.57% / -0.76% |
LoseNAGE / S&P NAGE unavailable / 7.68% |
LoseNAGE / S&P NAGE unavailable / 12.46% |
| 2017-Q41/3 |
WinNAGE / S&P 36.74% / 6.64% |
LoseNAGE / S&P NAGE unavailable / 7.03% |
LoseNAGE / S&P NAGE unavailable / 13.82% |
| 2017-Q31/3 |
WinNAGE / S&P 12.57% / 4.48% |
LoseNAGE / S&P NAGE unavailable / 5.68% |
LoseNAGE / S&P NAGE unavailable / 17.57% |
| 2017-Q21/3 |
WinNAGE / S&P 42.01% / 3.09% |
LoseNAGE / S&P NAGE unavailable / 4.83% |
LoseNAGE / S&P NAGE unavailable / 17.74% |
| 2017-Q10/3 |
LoseNAGE / S&P -18.73% / 6.07% |
LoseNAGE / S&P NAGE unavailable / 3.67% |
LoseNAGE / S&P NAGE unavailable / 13.32% |
| 2016-Q41/3 |
WinNAGE / S&P 11.07% / 3.82% |
LoseNAGE / S&P NAGE unavailable / 2.09% |
LoseNAGE / S&P NAGE unavailable / 7.05% |
| 2016-Q30/3 |
LoseNAGE / S&P -28.02% / 3.85% |
LoseNAGE / S&P NAGE unavailable / 0.20% |
LoseNAGE / S&P NAGE unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NAGE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -67.58% | 20.78% |
| Annualized return | -67.58% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | NAGE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -61.92% | 83.14% |
| Annualized return | -17.56% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | NAGE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -6.69% | 319.30% |
| Annualized return | -0.69% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |